MedPath
NMPA Approval

Tamsulosin Hydrochloride Oral Dispersible Sustained Release Tablets

国药准字J20140015

June 25, 2018

H20181114

Drug Information

盐酸坦索罗辛口崩缓释片

片剂

0.2mg

化学药品

June 25, 2018

Company Information

Applicant Company

5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411,Japan

Manufacturing Company

astellas pharma tech co., ltd. yaizu technology center

180 Ozumi, Yaizu-shi, Shizuoka 425-0072, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸坦索罗辛口崩缓释片 - NMPA 批准文号 | MedPath